Value-based care initiatives and ideas have really been growing over the past few years, with outcome-based arrangements being one of the newest ideas. Could this be the year it all takes off? Find out more here. (Source: Matthew Fisher, HiMSS, Linkedin) […]
Four Barriers to Value-Based Care
Humana recently funded a study by the American Academy of Family Physicians (AAFP) finding that physicians are still facing some of the same barriers to value-based payment arrangements. Roy Beveridge, MD, Managed Healthcare Executive editorial advisor and Humana's chief medical officer talk on […]
Prime Signs Boehringer to Value-Based Contract
Prime Therapeutics recently struck an outcomes-based coverage deal with Boehringer-Ingelheim for Jardiance, or empagliflozin, an SGLT2 inhibitor for type 2 diabetes. Read more here. (Source: SmartBrief, 2/5/18) […]
Could AI Take the Place of Your Doctor?
Computer algorithms may soon outperform human pathologists in both accuracy and speed, but rather than letting artificial intelligence (AI) take over the field, two pathology professors from Yale believe that AI will instead emerge as a powerful tool. Find out more here. (Source: Evan Sweeney, […]
Pfizer VP Talks Value Based Reimbursement
Managed Healthcare Executive talks with Pfizer's VP, Robert Popovian on Value-Based Reimbursement: the impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBRs successes and failures. Read more here. (Source: Tracey Walker, Managed Healthcare Executive, 1/24/18) […]
Six Healthcare Trends to Watch in 2018
2018 finds the U.S. health care industry on the edge of significant change. Despite shifting market trends and business realities, this article feels confident in making some predictions on what we may see in healthcare for 2018. Read more here. (Source: Health Affairs Blog, 1/29/18) […]
New Approaches to Value in Health and Care
This paper argues that accounting for value in health and care needs to take into account the value contributed by people and communities themselves (for example by managing their health successfully, caring for others, volunteering for community support); and the values that are important to people […]
Navigating to Value in Healthcare
Where data already exist, many healthcare leaders don't know how to find, retrieve, organize and leverage them for their needs. Navigating to Value in Healthcare author Thom Walsh, PhD, creates an antidote for this situation. You'll learn how to create systems and processes that help to leverage […]
Flexible Formularies – A New Patient-Centered Approach to Formulary Design
The current health reform debate will end in either a full replacement of the Affordable Care Act or, at the very least, a major facelift, but either way, patients are going to have to make some decisions about what constitutes value. Flexible formularies represent a new approach to designing […]
FDA On Drug Pricing: Incremental Steps, But No Full-Frontal Assault
Allowing manufacturers to communicate with payers about investigational and off-label uses is ‘beyond getting more information to the payers to validate the traditional reimbursement,’ [Susan Winckler, president of Leavitt Partners Consulting] said... Paid Subscription Required to Read More. […]
New PhRMA Survey Examines Barriers to Value-based Contracting
PhRMA recently conducted a pair of studies to determine payers' and members' perspectives on value-based contracts. Find out more about the legal, operational and regulatory barriers indicated in the new study here. (Source: The American Journal of Pharmacy Benefits, 5/5/17) […]
Stout Hill & Company, Specializing in Value-Based Payment and Care Models
Have you heard about the newly launched Stout Hill & Company? This consulting and training firm was recently founded by Josh Martin, an expert in value-based health care, and is specializing in value-based payment and care models. Find out more here. (Source: PR Newswire, 4/25/17) […]
MACRA Could Cause $250 Decrease in Hospital Reimbursement
A new study recently published in Health Affairs, found that hospitals would likely be most financially affected by changes from MACRA, potentially facing a $250 billion decrease over a 15-year period. Find out more here. (Source: Maria Castellucci, Modern Healthcare, 4/21/17) […]
Value-Based Health Care Gains Favor Among Employers
A growing number of employers are finding that taking matters into their own hands works best when it comes to improving employee health while managing costs. Part of an ongoing evolution moving away from a focus on volume and toward a focus on value, many employers are bucking the insurance […]
Embracing the Move Toward Value-Based Care
During a session at the recent Academy of Managed Care Pharmacy Annual Meeting, panelist discussed the move away from fee-for-service (FFS) and the embracing of value-based care contracts and accountable care organizations (ACOs). Learn more about what was discussed here. (Source: AJMC.com, 3/28/17) […]
Cost vs. Value: Earnings Calls Spotlight US Pricing Reforms
“...Ian Read, chair and CEO of US drug major Pfizer Inc., thinks newly appointed President Trump's propositions for regulatory changes for the pricing of medicines will benefit large, innovative pharma companies. ‘There are lots of ways, like changing regulations to allow value-based contracting […]
Are Pay-for-Performance Deals a Good Compromise?
When called to lower prices, pharmaceutical giants instead have suggested that perhaps refunding SOME of the money paid for drugs that do not work as expected, back to insurers. Although not a new idea, the concept of pay-for-performance has recently grown as the industry seeks to defuse criticism. […]
How do We Build the Future’s Value-Based Health Care System
Take a look at the accomplishments the U.S. has made in building a value based health care system as well a potential roadmap and vision for the future administration to continue in that progress. Read more here. (Source: Vindell Washington and Andy Slavitt, HealthAffairsBlog, 1/17/17) […]
Trump, Congress And The Future Of Value-Based Drug Contracting
CMS-driven experiments in value-based purchasing may slow in the new US administration but commercial pressures to price drugs according to their value will not. Subscription required. (Source: Cathy Kelly, Pink Sheet, 11/11/16) […]
Will Value-Based Payment Initiatives Survive Trump?
President-elect Donald Trump has promised to bring a lot of changes to the American healthcare system. How will those changes affect the current move towards value-based payment initiatives? Login required to read more here. (Source: Elizabeth Whitman, Modern Healthcare, 11/11/16) […]
What Will Trump do for Value-Based Healthcare?
Find out what healthcare IT experts say about how the Republican take over will affect key issues in US healthcare. Read more here. (Source: Rajiv Leventhal and Heather Landi, healthcare informatics, 11/9/16) […]
What is Clinton’s Stance on Value-Based Healthcare?
Value is the most important concept in healthcare today, but remains a challenge to implement, starting with the fact that no one can agree on a proper definition. What does Presidential candidate, Hillary Clinton say about a value-based healthcare, and how does she plan to incorporate it into her […]
Value Based Purchasing – Obamacare’s Missing Ingredient
Obamacare has been working hard on getting uninsured Americans covered by affordable insurance, however, insurance premiums keep rising and becoming Unaffordable to many Americans and without improving the quality of care received. Learn more about how a value based purchasing system could be the […]
Will Value Frameworks Create Real Change in Health Care?
The concept of value has become important in regards to pharmaceutical pricing and reimbursement, however, the definition of value has yet to be agreed on. The introduction of value frameworks has done well to move conversation, but will they be able to bring real change? Read more here. (Source: […]
How Should a Drug’s Value be Assessed and Reflected in its Price?
There's been a lot of discussion about value in healthcare lately, but how do you assess true value? How much does it depend on who you're asking? Read more here. (Source: Austin Frakt, news@JAMA, 7/13/16) […]
Perceptions of ICER Reports and HTA in the U.S.
Michael Barry, MD, PhD, clinical director at the National Centre for Pharmacoeconomics in Dublin, Ireland recently initiated a session with a presentation on how Institute for Clinical and Economic Review (ICER) reports will be relevant to organizational assessments. Find out more about "Payers' use […]
Value Calculators and the Future of Value-Based Medicine in Oncology
Dr. Bruce Feinberg, VP Chief Medical Officer Cardinal Health Specialty Solutions, recently sat down with Dr. Joseph Bailes, medical oncologist and past president of ASCO, to discuss the future of oncology research, practice, and patient care. Their conversation ran the gamut from value-based care […]
How Would the GOP Use Value-Based Insurance Design?
U.S. House Republicans recently released a white paper outlining a number of policy proposals aimed at lowering health care spending and delivering higher quality care, including the implementation of value-based insurance design. Find out more here. (Source: University of Michigan Center for […]
AMCP Recommendations for HCEI Sharing
The Academy of Managed Care Pharmacy (AMCP) recently released recommendations allowing biopharmaceutical companies to share health care economic information (HCEI) more easily. Learn more here. (Source: PR Newswire, 6/24/16) […]
ICER Releases Evidence Reports on Obeticholic Acid
The Institute for Clinical and Economic Review (ICER) recently released two Evidence Reports assessing the comparative clinical effectiveness and value of obeticholic acid (OCA) (Ocaliva). Find out more here. (Source: ICER, 6/23/16) […]
